Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04069923 · ClinicalTrials.gov registry record · NA
OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04069923 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 5 participants.
The verdict
NCT04069923, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This trial studies the side effects of OsteoCrete in filling bone voids in participants with bone voids or defects. OsteoCrete may eliminate the need for further surgery and the removal of healthy bone.
Interventions
- OTHER Magnesium-based Bone Void Filler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2022-01-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04069923
The ClinicalTrials.gov registry entry for NCT04069923 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magnesium-based Bone Void Filler is the first listed.
NCT04069923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04069923 about?
NCT04069923 is a clinical study titled "OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects". This trial studies the side effects of OsteoCrete in filling bone voids in participants with bone voids or defects. OsteoCrete may eliminate the need for further surgery and the removal of healthy bone.
What is the current status of trial NCT04069923?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-12-18. Estimated completion is 2022-01-17.
What interventions are being tested in trial NCT04069923?
The interventions under investigation include: Magnesium-based Bone Void Filler (OTHER).
Who is sponsoring clinical trial NCT04069923?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.